Comunicações em Eventos - LIM/15
Browse
Collection's Items (Sorted by Submit Date in Descending order): 1 to 20 of 209
Issue Date | Title | Author(s) |
---|---|---|
2023 | PATIENT AND CAREGIVER SPINAL MUSCULAR ATROPHY (SMA) TREATMENT ATTRIBUTE PREFERENCES IN LATIN AMERICA | SAENZ, V; CHLISTALLA, M.; CARLOS, N.; CASTIGLIONI, Toledo C.; SOLEDAD, Monges M.; SERVAIS, L.; ZANOTELI, E. |
2023 | LOXL3 knock out affects pathways which involve cytoskeleton regulation, proliferation and apoptosis in glioblastoma cells | LAURENTINO, Talita S.; SOARES, Roseli S.; LERARIO, Antonio M.; MARIE, Suely K.; OBA-SHINJO, Sueli Mieko |
2023 | Hemifacial Spasm: gene expression and immunohistochemical analysis | GAMEIRO, Gustavo; OSAKI, Midori; OSAKI, Teissy; CAMPOS, Eliene; MARIE, Suely; OSAKI, Tammy |
2021 | Metabolic and Structural Signatures in Corticobasal Syndrome: A Multimodal PET/MRI Study | CARNEIRO, G. C.; PARMERA, J. B.; ALMEIDA, I. J.; OLIVEIRA, M. C. B.; SILAGI, M. L.; STUDART-NETO, A.; ONO, C. R.; BARBOSA, E. R.; NITRINI, R.; BUCHPIGUEL, C. A., et al |
2023 | Epigenetic dedifferentiation as a therapeutic strategy in adrenal cancer | MOHAN, Dipika R.; BORGES, Kleiton S.; FINCO, Isabella; LAPENSEE, Christopher R.; REGE, Juilee; LITTLE, Donald W.; ELSE, Tobias; ALMEIDA, Madson Q.; DANG, Derek; HAGGERTY-SKEANS, James, et al |
2019 | Peripheral Nerve Stimulation to Enhance Upper Limb Motor Function in Stroke | CONFORTO, Adriana B.; LUCCAS, Rafael; MENEZES, Isabella S.; MACHADO, Andre G.; MELLO, Eduardo A.; ASSIS, Priscila S.; FREITAS, Paloma F.; PIRES, Danielle S.; PECKHAM, Paul H.; COHEN, Leonardo G. |
2023 | FIREFISH Parts 1 and 2: 36-month safety and efficacy of risdiplam in Type 1 spinal muscular atrophy (SMA) | DARRAS, Basil; BARANELLO, Giovanni; BOESPFLUG-TANGUY, Odile; DAY, John; DECONINCK, Nicholas; KLEIN, Andrea; MASSON, Ricardo; MAZURKIEWICZ-BELDZINSKA, Maria; MERCURI, Eugenio; ROSE, Kristy, et al |
2023 | FIREFISH Parts 1 and 2: 4-year efficacy and safety of risdiplam in Type 1 spinal muscular atrophy (SMA) | MAZURKIEWICZ-BELDZINSKA, M.; BARANELLO, G.; BOESPFLUG-TANGUY, O.; DAY, J.; DECONINCK, N.; KLEIN, A.; MASSON, R.; MERCURI, E.; ROSE, K.; SERVAIS, L., et al |
2022 | New developments and data highlights in the international myotubular and centronuclear myopathy patient registry | LAITILA, J.; RANU, N.; MARIANO, J.; WALLGREN-PETTERSSON, C.; WITTING, N.; VISSING, J.; VILCHEZ, J.; FIORILLO, C.; ZANOTELI, E.; AURANEN, M., et al |
2022 | Myosin dysregulation in nemaline myopathy | LAITILA, J.; RANU, N.; MARIANO, J.; WALLGREN-PETTERSSON, C.; WITTING, N.; VISSING, J.; VILCHEZ, J.; FIORILLO, C.; ZANOTELI, E.; AURANEN, M., et al |
2022 | RAINBOWFISH: Preliminary efficacy and safety data in risdiplam-treated infants with presymptomatic spinal muscular atrophy (SMA) | FINKEL, R.; FARRAR, M.; VLODAVETS, D.; ZANOTELI, E.; AL-MUHAIZEA, M.; NELSON, L.; PRUFER, A.; SERVAIS, L.; WANG, Y.; FISHER, C., et al |
2022 | FIREFISH Parts 1 and 2: 24-month Safety and Efficacy of Risdiplam in Type 1 SMA | DARRAS, Basil T.; BOESPFLUG-TANGUY, Odile; DAY, John W.; DECONINCK, Nicolas; KLEIN, Andrea; MASSON, Riccardo; MAZURKIEWICZ-BELDZINSKA, Maria; MERCURI, Eugenio; ROSE, Kristy; SERVAIS, Laurent, et al |
2022 | FIREFISH Parts 1 and 2: 36-month safety and efficacy of risdiplam in Type 1 spinal muscular atrophy (SMA) | SERVAIS, L.; BARANELLO, G.; BOESPFLUG-TANGUY, O.; DAY, J.; DECONINCK, N.; KLEIN, A.; MASSON, R.; MAZURKIEWICZ-BELDZINSKA, M.; MERCURI, E.; ROSE, K., et al |
2022 | RAINBOWFISH: Preliminary Efficacy and Safety Data in Risdiplam-Treated Infants with Presymptomatic SMA | FINKEL, Richard S.; FARRAR, Michelle A.; VLODAVETS, Dmitry; SERVAIS, Laurent; ZANOTELI, Edmar; AL-MUHAIZEA, Mohammad; NELSON, Leslie; PRUFER, Alexandra; WANG, Yi; FISHER, Carolyn, et al |
2022 | Probable Four-repeat tauopathy criteria in Corticobasal Syndrome: diagnostic accuracy, clinical features and imaging biomarkers | PARMERA, J.; CARNEIRO, C.; OLIVEIRA, M.; BARBOSA, P.; BUCHPIGUEL, C.; NITRINI, R.; BARBOSA, E.; BRUCKI, S.; COUTINHO, A. |
2018 | Corticobasal Syndrome variants: Is functional nuclear imaging with FDG-PET or SPECT patterns capable of predicting clinical features? | PARMERA, J.; COUTINHO, A. M.; ARANHA, M. R.; STUDART, A.; ONO, C. R.; NITRINI, R.; BUCHPIGUEL, C. A.; BRUCKI, S. |
2022 | FIREFISH Parts 1 and 2: 36-month safety and efficacy of risdiplam in Type 1 spinal muscular atrophy | DECONINCK, N.; BARANELLO, G.; BOESPFLUG-TANGUY, O.; DAY, J.; KLEIN, A.; MASSON, R.; MAZURKIEWICZ-BELDZINSKA, M.; MERCURI, E.; ROSE, K.; SERVAIS, L., et al |
2021 | IMPACT OF COVID-19 PANDEMIC ON MENTAL HEALTH, SOCIAL CONNECTEDNESS AND COGNITIVE PERFORMANCE OF OLDER ADULTS | SOUZA-TALARICO, Juliana; SILVA, Fernanda; JESUS, Maria Clara; BARBOSA, Breno J. A. P.; NITRINI, Ricardo; BRUCKI, Sonia M. D. |
2022 | Quality Of Ischemic Stroke Care Before And After The Covid-19 Pandemic | CONFORTO, Adriana B. |
2017 | Five-year follow-up of pediatric onset Neuromyelitis Optica Spectrum Disorders (NMOSD) | PAOLILO, R. B.; PAZ, J. A.; APOSTOLOS-PEREIRA, S. L.; RIMKUS, C. D. M.; ARAUJO, A. L. P. C.; VENTURA, L. M. G. D. B.; PITOMBEIRA, M. S.; GOMES, A. B.; MATOS, A. D. M. B.; TORRETTA, P. H. B., et al |
Collection's Items (Sorted by Submit Date in Descending order): 1 to 20 of 209